跳至主要内容
临床试验/NCT04785534
NCT04785534进行中(未招募)不适用

Patient-Centered Liver Cancer Prevention in the Houston Community Screening for Predictors of Fibrosis and Cirrhosis

M.D. Anderson Cancer Center1 个研究点 分布在 1 个国家目标入组 1,000 人开始时间: 2020年12月22日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
进行中(未招募)
入组人数
1,000
试验地点
1
主要终点
Positive hepatitis B surface antigen test result

研究概览

简要总结

This clinical trial studies the use of surveys, blood testing, and fibroscan in screening for liver fibrosis and liver cirrhosis in new or existing patients of the HOPE clinic seeking usual clinical care. Fibroscan is an imaging procedure of the liver which uses a probe like an ultrasound. Information gathered from this study may help researchers learn more about how to prevent or find liver cancer in patients who are currently receiving care at the HOPE clinic. Early detection of liver cancer may improve survival.

详细描述

PRIMARY OBJECTIVE:

I. To estimate the sensitivity of the modified Center for Disease Control (CDC) hepatitis survey in diagnosing chronic hepatitis B virus (HBV) among HOPE clinic patient.

SECONDARY OBJECTIVES:

I. To estimate the sensitivity of the modified CDC hepatitis survey in identifying chronic active hepatitis C virus (HCV) infection among HOPE clinic patients.

II. To estimate the sensitivity of fibrosis serum biomarkers, non-alcoholic fatty liver disease fibrosis score (NFS), fibrosis-4 index (FIB-4), and fatty liver index (FLI) in detecting fibrosis (fibroscan result >= F2) among HOPE clinic patients with metabolic conditions.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Screening
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Must be at least 18 years old
  • Must be a new or existing patient of the HOPE clinic seeking usual clinical care
  • Must be able to speak and read English or a language other than English for which there is a translator available on site at the HOPE clinic

排除标准

  • Known pregnancy at time of recruitment. The HOPE clinic will ask the female patients if they are pregnant, will ask the participants for their last menstrual period (LMP), and/or they will use the urine pregnancy test (UPT) results in their electronic medical records

研究组 & 干预措施

Screening (survey, biomarker analysis, fibroscan)

Experimental

Patients complete surveys over 10-15 minutes, and undergo blood testing, clinical evaluation, and fibroscan at baseline.

干预措施: Clinical Evaluation (Other)

Screening (survey, biomarker analysis, fibroscan)

Experimental

Patients complete surveys over 10-15 minutes, and undergo blood testing, clinical evaluation, and fibroscan at baseline.

干预措施: Laboratory Biomarker Analysis (Other)

Screening (survey, biomarker analysis, fibroscan)

Experimental

Patients complete surveys over 10-15 minutes, and undergo blood testing, clinical evaluation, and fibroscan at baseline.

干预措施: Liver Ultrasonographic Elastography (Procedure)

Screening (survey, biomarker analysis, fibroscan)

Experimental

Patients complete surveys over 10-15 minutes, and undergo blood testing, clinical evaluation, and fibroscan at baseline.

干预措施: Survey Administration (Other)

结局指标

主要结局

Positive hepatitis B surface antigen test result

时间窗: At baseline

The presence of at least one risk factor for hepatitis B virus (HBV) on the screening questionnaire will indicate a positive (versus negative) screening for HBV infection.

次要结局

  • Positive anti-hepatitis C virus (HCV) test result(At baseline)
  • Fibroscan result >= F2(Up to 3 months)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验